Home Cart Sign in  
Chemical Structure| 89898-96-4 Chemical Structure| 89898-96-4

Structure of 89898-96-4

Chemical Structure| 89898-96-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 89898-96-4 ]

CAS No. :89898-96-4
Formula : C8H5N3O3
M.W : 191.14
SMILES Code : [N+](=O)([O-])C1=CC=C2C(=C1)NC(C=N2)=O
MDL No. :MFCD09999191
InChI Key :CPIFPSDSDMLFMK-UHFFFAOYSA-N
Pubchem ID :15025857

Safety of [ 89898-96-4 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 89898-96-4 ] Show Less

Physicochemical Properties

Num. heavy atoms 14
Num. arom. heavy atoms 10
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 4.0
Num. H-bond donors 1.0
Molar Refractivity 51.19
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

91.57 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.86
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.63
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.83
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.3
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.12
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.38

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.88
Solubility 2.49 mg/ml ; 0.013 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.13
Solubility 1.42 mg/ml ; 0.00745 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.62
Solubility 0.46 mg/ml ; 0.0024 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.02 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.16

Application In Synthesis of [ 89898-96-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 89898-96-4 ]
  • Downstream synthetic route of [ 89898-96-4 ]

[ 89898-96-4 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 1196-57-2 ]
  • [ 89898-96-4 ]
References: [1] Chemical and Pharmaceutical Bulletin, 2007, vol. 55, # 2, p. 255 - 267.
[2] Yakugaku Zasshi, 1959, vol. 79, p. 658[3] Chem.Abstr., 1959, p. 21979.
  • 2
  • [ 99-56-9 ]
  • [ 6295-06-3 ]
  • [ 89898-96-4 ]
  • [ 25652-34-0 ]
References: [1] Journal of the American Chemical Society, 1949, vol. 71, p. 6,7.
  • 3
  • [ 55686-94-7 ]
  • [ 89898-96-4 ]
References: [1] Journal of the Chemical Society, 1956, p. 26,27.
[2] Justus Liebigs Annalen der Chemie, 1953, vol. 579, p. 212,220.
[3] Yakugaku Zasshi, 1959, vol. 79, p. 658[4] Chem.Abstr., 1959, p. 21979.
  • 4
  • [ 5310-52-1 ]
  • [ 89898-96-4 ]
References: [1] Justus Liebigs Annalen der Chemie, 1953, vol. 579, p. 212,220.
[2] Gazzetta Chimica Italiana, 1957, vol. 87, p. 354,365.
  • 5
  • [ 924-44-7 ]
  • [ 99-56-9 ]
  • [ 89898-96-4 ]
  • [ 25652-34-0 ]
References: [1] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 21, p. 3153 - 3156.
  • 6
  • [ 1084-76-0 ]
  • [ 89898-96-4 ]
References: [1] Gazzetta Chimica Italiana, 1957, vol. 87, p. 354,365.
  • 7
  • [ 99-56-9 ]
  • [ 89898-96-4 ]
References: [1] Gazzetta Chimica Italiana, 1957, vol. 87, p. 354,365.
  • 8
  • [ 99-56-9 ]
  • [ 6065-82-3 ]
  • [ 89898-96-4 ]
  • [ 25652-34-0 ]
References: [1] Justus Liebigs Annalen der Chemie, 1953, vol. 579, p. 212,220.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 89898-96-4 ]

Amides

Chemical Structure| 69904-06-9

A231645 [69904-06-9]

6-Aminoquinoxalin-2(1H)-one

Similarity: 0.69

Chemical Structure| 2427-71-6

A181282 [2427-71-6]

6-Chloro-2(1H)-quinoxalinone

Similarity: 0.69

Chemical Structure| 17090-15-2

A168313 [17090-15-2]

N-(3-Nitrophenyl)acrylamide

Similarity: 0.69

Chemical Structure| 4850-93-5

A213715 [4850-93-5]

N-(4-Nitrophenyl)propionamide

Similarity: 0.64

Chemical Structure| 881-50-5

A238553 [881-50-5]

N-(4-Bromo-2-nitrophenyl)acetamide

Similarity: 0.63

Nitroes

Chemical Structure| 17090-15-2

A168313 [17090-15-2]

N-(3-Nitrophenyl)acrylamide

Similarity: 0.69

Chemical Structure| 1792-40-1

A143755 [1792-40-1]

2-Methyl-5-nitro-1H-benzo[d]imidazole

Similarity: 0.68

Chemical Structure| 4850-93-5

A213715 [4850-93-5]

N-(4-Nitrophenyl)propionamide

Similarity: 0.64

Chemical Structure| 76320-88-2

A226948 [76320-88-2]

2-Methyl-4-nitro-1H-benzo[d]imidazole

Similarity: 0.64

Chemical Structure| 18514-76-6

A599476 [18514-76-6]

5-Nitroquinoxaline

Similarity: 0.63

Related Parent Nucleus of
[ 89898-96-4 ]

Quinoxalines

Chemical Structure| 69904-06-9

A231645 [69904-06-9]

6-Aminoquinoxalin-2(1H)-one

Similarity: 0.69

Chemical Structure| 2427-71-6

A181282 [2427-71-6]

6-Chloro-2(1H)-quinoxalinone

Similarity: 0.69

Chemical Structure| 18514-76-6

A599476 [18514-76-6]

5-Nitroquinoxaline

Similarity: 0.63

Chemical Structure| 41959-35-7

A293143 [41959-35-7]

6-Nitro-1,2,3,4-tetrahydroquinoxaline

Similarity: 0.61

Chemical Structure| 82031-32-1

A284838 [82031-32-1]

7-Bromoquinoxalin-2(1H)-one

Similarity: 0.61